XW0E33B Introduction of DB-OTO via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11
Billable / valid for submission ICD10PCS Release FY2026-APR
Description changes on October 1, 2026 in FY2027, to: Introduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11
Short description: Introduce DB-OTO Intrcochl in Ear(s), Perc, New Tech 11
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026-APR | 2026-04-01 | current | Introduction of DB-OTO via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11 | yes |
Related codes in XW0
- XW0 New Technology, Anatomical Regions, Introduction
- XW00X27 Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7
- XW01318 Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8
- XW01329 Introduction of Talquetamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
- XW01348 Introduction of Teclistamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8
- XW0136A Introduction of Dasiglucagon into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 10